SLNO
SLNO
NASDAQ · Biotechnology

Soleno Therapeutics Inc

$31.04
-0.68 (-2.14%)
As of Mar 24, 1:40 PM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -35.7% upside
Low Target $16.99
Average Target $19.95
High Target $27.29
Current Price $31.04
Current
$31.04
Target
$19.95
$16.99 $19.95 avg $27.29
Scenario Analysis
Bear Case
$16.99
-45.3%
Low target
Base Case
$19.95
-35.7%
Avg target
Bull Case
$27.29
+-12.1%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$90.32
-65.6% from high
52-Week Low
$32.15
+-3.5% from low
50-Day SMA
$44.35
-30.0% vs SMA
200-Day SMA
$63.31
-51.0% vs SMA
RSI (14)
47.2
Neutral
Target vs 52W High
$19.95
-77.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -26.5%